Trends and geographic variation in women's representation as principal investigators (PI) in phase 3 gynecologic oncology clinical trials

CONCLUSIONS: Women's representation as PIs in clinical trials has increased in the last decade. Trials funded by multiple sources outside of Asia have the highest proportion of PIs who are women. These trends may represent ongoing leadership and mentorship opportunities for women gynecologic oncologists.PMID:34099315 | DOI:10.1016/j.ygyno.2021.05.037
Source: Gynecologic Oncology - Category: Cancer & Oncology Authors: Source Type: research